Relative Sarcopenia and Cardiometabolic Risk in Young Adults with Obesity
肥胖年轻人的相对肌肉减少症和心脏代谢风险
基本信息
- 批准号:10240291
- 负责人:
- 金额:$ 19.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-12 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AdultAge FactorsAppointmentAtherosclerosis Risk in CommunitiesAwardBody mass indexCardiometabolic DiseaseCenter for Translational Science ActivitiesCentral obesityClinicalClinical InvestigatorClinical ResearchClinical SciencesCoronary Artery Risk Development in Young Adults StudyDataDepositionElderlyEndocrine PhysiologyEnvironmentEpidemiologyFacultyFatty acid glycerol estersFosteringFundingFutureGeneral HospitalsGenetic RiskGlucoseGoalsGrantHormonesHospital DepartmentsImaging TechniquesImpairmentInsulin ResistanceLeadLinkLipidsMassachusettsMediatingMedicineMentored Patient-Oriented Research Career Development AwardMentorsMentorshipMuscleNational Health and Nutrition Examination SurveyNeuroendocrinologyNeurosecretory SystemsNon-Insulin-Dependent Diabetes MellitusObesityOverweightPeripheralPhenotypePrevalencePreventionProspective StudiesPublic HealthPublicationsRadiology SpecialtyResearchResearch PersonnelResearch SupportResourcesRiskRisk FactorsSingle Nucleotide PolymorphismSkeletal MuscleSomatotropinStudy SubjectTargeted ResearchTestosteroneThinnessTimeTrainingUnited States National Institutes of HealthVisitWomanadiponectinadult obesitycardiometabolic riskcareerdesigndiabetes riskfollow-upgenetic epidemiologygenetic varianthormone deficiencyinstructorlifestyle factorsmedical schoolsmenmitochondrial dysfunctionmultidisciplinarymuscle formmusculoskeletal imagingpatient orientedprogramsrecruitreduced muscle massrisk prediction modelsarcopeniasexskillssuccessyoung adult
项目摘要
PROJECT SUMMARY/ABSTRACT
Obesity is a well-known cardiometabolic disease risk factor and growing public health problem. However, little
is known about the impact of muscle mass and quality on cardiometabolic risk, including type 2 diabetes (DM),
especially in young adults with overweight/obesity. The proposed research has the potential to identify targets
for the prevention and treatment of this public health problem.
The central hypothesis is that relative sarcopenia (i.e. low muscle mass relative to BMI) and impaired muscle
quality (i.e. intramyocellular lipid (IMCL) and mitochondrial dysfunction) contribute to higher DM risk over time
in young adults with overweight/obesity. We also hypothesize that common genetic variants associated with
insulin resistance, as well as obesity-related relative hormone deficiencies, contribute to relative sarcopenia
and impaired muscle quality and lead to higher DM risk.
The candidate is an Instructor of Medicine at Harvard Medical School and Assistant in Medicine at
Massachusetts General Hospital (MGH) who is highly qualified for and deeply committed to developing a
career as an independent investigator. Her short-term goal is to develop the skills and obtain the preliminary
data necessary to make the transition to her first R-level independent NIH grant-supported research. Her long-
term goal is to become an independent patient-oriented researcher leveraging genetic epidemiology, endocrine
physiology and sophisticated imaging techniques to elucidate mechanisms that may contribute to increased
cardiometabolic risk in young adults with overweight/obesity, and to identify potential targets for both
prevention and treatment. She has an outstanding track record of success, including awards, pilot grants and
publications, and is supported by an expert and highly invested mentorship team composed of successful,
NIH-supported clinical investigators in Neuroendocrinology, Radiology, Epidemiology and Genetic
Epidemiology. She and her mentors have designed a targeted training plan consisting of co-mentorship and a
didactic program.
The institutional environment is outstanding at MGH and Harvard Medical School, with multiple resources
available from the MGH Department of Medicine, the MGH Division of Clinical Research, and the Harvard
Clinical and Translational Science Center, all of which offer a myriad of didactic opportunities, facilities and
support to the candidate. The Neuroendocrine Unit and Department of Medicine have made a strong
commitment to the candidate, including 90% protected time, space, study coordinator support and a faculty
appointment, with the goal of fostering the candidate's career as an independent investigator.
项目概要/摘要
肥胖是众所周知的心脏代谢疾病危险因素和日益严重的公共卫生问题。然而,很少
了解肌肉质量和质量对心脏代谢风险的影响,包括 2 型糖尿病 (DM),
尤其是超重/肥胖的年轻人。拟议的研究有可能确定目标
以预防和治疗这一公共卫生问题。
中心假设是相对肌肉减少症(即相对于 BMI 的肌肉质量较低)和肌肉受损
随着时间的推移,质量(即肌细胞内脂质 (IMCL) 和线粒体功能障碍)会导致更高的 DM 风险
超重/肥胖的年轻人。我们还假设常见的遗传变异与
胰岛素抵抗以及与肥胖相关的相对激素缺乏会导致相对肌肉减少症
和肌肉质量受损并导致更高的 DM 风险。
该候选人是哈佛医学院的医学讲师和医学助理
马萨诸塞州总医院 (MGH) 拥有高素质并坚定致力于发展
独立调查员的职业生涯。她的短期目标是发展技能并获得初步的
过渡到她的第一个 R 级独立 NIH 拨款支持的研究所需的数据。她的长——
学期目标是成为一名独立的、以患者为导向的研究人员,利用遗传流行病学、内分泌学
生理学和复杂的成像技术来阐明可能有助于增加的机制
超重/肥胖年轻人的心脏代谢风险,并确定两者的潜在目标
预防和治疗。她拥有杰出的成功记录,包括奖项、试点补助金和
出版物,并得到专家和高度投入的指导团队的支持,该团队由成功的、
NIH 支持的神经内分泌学、放射学、流行病学和遗传学临床研究人员
流行病学。她和她的导师设计了一个有针对性的培训计划,包括共同指导和
教学计划。
MGH和哈佛医学院机构环境优秀,资源多元
可从 MGH 医学系、MGH 临床研究部和哈佛大学获取
临床和转化科学中心,所有这些中心都提供无数的教学机会、设施和
对候选人的支持。神经内分泌科和医学科已做出了强有力的贡献
对候选人的承诺,包括 90% 受保护的时间、空间、学习协调员支持和教师
任命,目的是促进候选人作为独立调查员的职业生涯。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Melanie Schorr Haines其他文献
Melanie Schorr Haines的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Melanie Schorr Haines', 18)}}的其他基金
Effects of bimagrumab on body composition, insulin sensitivity, and bone in adults with obesity
bimagrumab 对肥胖成人的身体成分、胰岛素敏感性和骨骼的影响
- 批准号:
10716254 - 财政年份:2023
- 资助金额:
$ 19.83万 - 项目类别:
Effects of semaglutide on bone and muscle endpoints in adults with obesity: a pilot study.
索马鲁肽对肥胖成人骨骼和肌肉终点的影响:一项试点研究。
- 批准号:
10543992 - 财政年份:2022
- 资助金额:
$ 19.83万 - 项目类别:
Effects of semaglutide on bone and muscle endpoints in adults with obesity: a pilot study.
索马鲁肽对肥胖成人骨骼和肌肉终点的影响:一项试点研究。
- 批准号:
10350212 - 财政年份:2022
- 资助金额:
$ 19.83万 - 项目类别:
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with Obesity
肥胖年轻人的相对肌肉减少症和心脏代谢风险
- 批准号:
10469729 - 财政年份:2017
- 资助金额:
$ 19.83万 - 项目类别:
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with Obesity
肥胖年轻人的相对肌肉减少症和心脏代谢风险
- 批准号:
10220356 - 财政年份:2017
- 资助金额:
$ 19.83万 - 项目类别:
Relative Sarcopenia and Cardiometabolic Risk in Young Adults with Obesity
肥胖年轻人的相对肌肉减少症和心脏代谢风险
- 批准号:
9757757 - 财政年份:2017
- 资助金额:
$ 19.83万 - 项目类别:
相似国自然基金
季节性因素影响下Wolbachia对具有年龄结构的蚊媒及蚊媒病的控制
- 批准号:11901247
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
基于年龄因素的白眉姬鹟繁殖对策调整与繁殖功效研究
- 批准号:31801976
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
儿童区分真实和虚幻的神经机制:年龄特征和影响因素
- 批准号:31700968
- 批准年份:2017
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
老龄化对牙周膜干细胞增殖及分化能力的影响及其机制研究
- 批准号:81500853
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
大鼠骨骼肌快肌纤维和慢肌纤维NMJ功能与年龄相关的变化及其影响因素分析
- 批准号:31460275
- 批准年份:2014
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Prospective Memory in Everyday Life: Lapses and Decline in Relation to Inflammatory and Neurodegenerative Biomarkers in Older Adults
日常生活中的预期记忆:与老年人炎症和神经退行性生物标志物相关的衰退和下降
- 批准号:
10644046 - 财政年份:2023
- 资助金额:
$ 19.83万 - 项目类别:
Increasing initiation of evidence-based weight loss treatment
越来越多地开始开展循证减肥治疗
- 批准号:
10735201 - 财政年份:2023
- 资助金额:
$ 19.83万 - 项目类别:
Pandemic Acceptance and Commitment Therapy (Pan-ACT): Feasibility and Acceptability of Telehealth Delivery with Older Veterans
流行病接受和承诺疗法(Pan-ACT):老年退伍军人远程医疗服务的可行性和可接受性
- 批准号:
10655582 - 财政年份:2022
- 资助金额:
$ 19.83万 - 项目类别:
Impact of Social Determinants of Health in Diabetic Retinopathy
健康社会决定因素对糖尿病视网膜病变的影响
- 批准号:
10622501 - 财政年份:2022
- 资助金额:
$ 19.83万 - 项目类别:
Developing and Testing a Population Health Approach to Deprescribing and Optimizing Medications in Older Adults
开发和测试人口健康方法以减少和优化老年人的药物治疗
- 批准号:
10428280 - 财政年份:2022
- 资助金额:
$ 19.83万 - 项目类别: